Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
fatigue; Patient had some soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and VACCINATION SITE PAIN (Patient had some soreness at the injection site) in an adult female patient who received mRNA-1283 (MNEXSPIKE PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Sep-2025, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue) and VACCINATION SITE PAIN (Patient had some soreness at the injection site). At the time of the report, FATIGUE (fatigue) and VACCINATION SITE PAIN (Patient had some soreness at the injection site) outcome was unknown. No concomitant medications were reported. Patient had some soreness at the injection site and fatigue, but nothing horrible. Patient's husband had no side effects after receiving suspect vaccine. No treatment medications were reported. It was unknown if the patient experienced any additional symptoms/events.